Cargando…

Evaluation of two sexual-stage antigens as bivalent transmission-blocking vaccines in rodent malaria

BACKGROUND: Transmission-blocking vaccine (TBV) is a promising strategy for malaria elimination. It is hypothesized that mixing or fusing two antigens targeting different stages of sexual development may provide higher transmission-blocking activity than these antigens used individually. METHODS: A...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Fan, Liu, Fei, Yu, Xinxin, Zheng, Wenqi, Wu, Yudi, Qiu, Yue, Jin, Ying, Cui, Liwang, Cao, Yaming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103607/
https://www.ncbi.nlm.nih.gov/pubmed/33962671
http://dx.doi.org/10.1186/s13071-021-04743-0
_version_ 1783689339759230976
author Yang, Fan
Liu, Fei
Yu, Xinxin
Zheng, Wenqi
Wu, Yudi
Qiu, Yue
Jin, Ying
Cui, Liwang
Cao, Yaming
author_facet Yang, Fan
Liu, Fei
Yu, Xinxin
Zheng, Wenqi
Wu, Yudi
Qiu, Yue
Jin, Ying
Cui, Liwang
Cao, Yaming
author_sort Yang, Fan
collection PubMed
description BACKGROUND: Transmission-blocking vaccine (TBV) is a promising strategy for malaria elimination. It is hypothesized that mixing or fusing two antigens targeting different stages of sexual development may provide higher transmission-blocking activity than these antigens used individually. METHODS: A chimeric protein composed of fragments of Pbg37 and PSOP25 was designed and expressed the recombinant protein in Escherichia coli Rosetta-gami B (DE3). After immunizing mice with individual recombinant proteins Pbg37 and PSOP25, mixed proteins (Pbg37+PSOP25), or the fusion protein (Pbg37-PSOP25), the antibody titers of individual sera were analyzed by ELISA. IFA and Western blot were performed to test the reactivity of the antisera with the native proteins in the parasite. The transmission-blocking activity of the different immunization schemes was assessed using in vitro and in vivo assays. RESULTS: When Pbg37 and PSOP25 were co-administered in a mixture or as a fusion protein, they elicited similar antibody responses in mice as single antigens without causing immunological interference with each other. Antibodies against the mixed or fused antigens recognized the target proteins in the gametocyte, gamete, zygote, and ookinete stages. The mixed proteins or the fusion protein induced antibodies with significantly stronger transmission-reducing activities in vitro and in vivo than individual antigens. CONCLUSIONS: There was no immunological interference between Pbg37 and PSOP25. The bivalent vaccines, which expand the portion of the sexual development during which the transmission-blocking antibodies act, produced significantly stronger transmission-reducing activities than single antigens. Altogether, these data provide the theoretical basis for the development of combination TBVs targeting different sexual stages. GRAPHIC ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13071-021-04743-0.
format Online
Article
Text
id pubmed-8103607
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-81036072021-05-10 Evaluation of two sexual-stage antigens as bivalent transmission-blocking vaccines in rodent malaria Yang, Fan Liu, Fei Yu, Xinxin Zheng, Wenqi Wu, Yudi Qiu, Yue Jin, Ying Cui, Liwang Cao, Yaming Parasit Vectors Research BACKGROUND: Transmission-blocking vaccine (TBV) is a promising strategy for malaria elimination. It is hypothesized that mixing or fusing two antigens targeting different stages of sexual development may provide higher transmission-blocking activity than these antigens used individually. METHODS: A chimeric protein composed of fragments of Pbg37 and PSOP25 was designed and expressed the recombinant protein in Escherichia coli Rosetta-gami B (DE3). After immunizing mice with individual recombinant proteins Pbg37 and PSOP25, mixed proteins (Pbg37+PSOP25), or the fusion protein (Pbg37-PSOP25), the antibody titers of individual sera were analyzed by ELISA. IFA and Western blot were performed to test the reactivity of the antisera with the native proteins in the parasite. The transmission-blocking activity of the different immunization schemes was assessed using in vitro and in vivo assays. RESULTS: When Pbg37 and PSOP25 were co-administered in a mixture or as a fusion protein, they elicited similar antibody responses in mice as single antigens without causing immunological interference with each other. Antibodies against the mixed or fused antigens recognized the target proteins in the gametocyte, gamete, zygote, and ookinete stages. The mixed proteins or the fusion protein induced antibodies with significantly stronger transmission-reducing activities in vitro and in vivo than individual antigens. CONCLUSIONS: There was no immunological interference between Pbg37 and PSOP25. The bivalent vaccines, which expand the portion of the sexual development during which the transmission-blocking antibodies act, produced significantly stronger transmission-reducing activities than single antigens. Altogether, these data provide the theoretical basis for the development of combination TBVs targeting different sexual stages. GRAPHIC ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13071-021-04743-0. BioMed Central 2021-05-07 /pmc/articles/PMC8103607/ /pubmed/33962671 http://dx.doi.org/10.1186/s13071-021-04743-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Yang, Fan
Liu, Fei
Yu, Xinxin
Zheng, Wenqi
Wu, Yudi
Qiu, Yue
Jin, Ying
Cui, Liwang
Cao, Yaming
Evaluation of two sexual-stage antigens as bivalent transmission-blocking vaccines in rodent malaria
title Evaluation of two sexual-stage antigens as bivalent transmission-blocking vaccines in rodent malaria
title_full Evaluation of two sexual-stage antigens as bivalent transmission-blocking vaccines in rodent malaria
title_fullStr Evaluation of two sexual-stage antigens as bivalent transmission-blocking vaccines in rodent malaria
title_full_unstemmed Evaluation of two sexual-stage antigens as bivalent transmission-blocking vaccines in rodent malaria
title_short Evaluation of two sexual-stage antigens as bivalent transmission-blocking vaccines in rodent malaria
title_sort evaluation of two sexual-stage antigens as bivalent transmission-blocking vaccines in rodent malaria
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103607/
https://www.ncbi.nlm.nih.gov/pubmed/33962671
http://dx.doi.org/10.1186/s13071-021-04743-0
work_keys_str_mv AT yangfan evaluationoftwosexualstageantigensasbivalenttransmissionblockingvaccinesinrodentmalaria
AT liufei evaluationoftwosexualstageantigensasbivalenttransmissionblockingvaccinesinrodentmalaria
AT yuxinxin evaluationoftwosexualstageantigensasbivalenttransmissionblockingvaccinesinrodentmalaria
AT zhengwenqi evaluationoftwosexualstageantigensasbivalenttransmissionblockingvaccinesinrodentmalaria
AT wuyudi evaluationoftwosexualstageantigensasbivalenttransmissionblockingvaccinesinrodentmalaria
AT qiuyue evaluationoftwosexualstageantigensasbivalenttransmissionblockingvaccinesinrodentmalaria
AT jinying evaluationoftwosexualstageantigensasbivalenttransmissionblockingvaccinesinrodentmalaria
AT cuiliwang evaluationoftwosexualstageantigensasbivalenttransmissionblockingvaccinesinrodentmalaria
AT caoyaming evaluationoftwosexualstageantigensasbivalenttransmissionblockingvaccinesinrodentmalaria